GHRL and obesity due to melanocortin 4 receptor deficiency: Thus, it is conceivable that RYGB may reverse blunted ghrelin signaling in obesity [34], [35], which acting upstream on the dopamine neurons [36], [37], [38], may alleviate reward deficits associated with dietary obesity [39].